Meet the MedCity Media Team

And take 2 minutes to help us make better for you.

Every year, we ask you to tell us a little about yourself (anonymously) to help us create better, more relevant content and features for you. We consider every response and very much appreciate you taking the time to assist us.

Please click the button above to open a simple, multiple choice survey that should only take 2 minutes to complete.

Thank you,

The MedCity Media Team

Gilead to buy YM BioSciences for about $465 million

11:06 am by | 0 Comments

(Reuters) - Gilead Sciences Inc will buy Canada's YM BioSciences Inc for about $465 million to gain access to its blood and immune cell disorder drugs.

Gilead said it will pay $2.95 per YM share.

YM shares closed at C$1.66 on Tuesday on the Toronto Stock Exchange.

(Reporting by Adithya Venkatesan and Shounak Dasgupta in Bangalore; Editing by Roshni Menon)


Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.